What: MassBio’s 4th Annual Equity, Diversity, and Inclusion (ED&I) Conference will bring together life sciences leaders from across Massachusetts and beyond to learn, connect, and take action within their organizations, communities, and throughout the ecosystem at large. Through keynotes and panel discussions, experts will share their insights on how leaders can authentically navigate internal and external calls for corporate social justice, how employers can improve the employee experience in the “next normal,” how the ecosystem can better build, cultivate, and support diverse talent.
When: Tuesday, August 18th, 2020 at 10:00 am – 12:15 PM.
Where: The 4th Annual ED&I Conference will be held virtually via Engagez.
Who: MassBio President & COO, Kendalle Burlin O’Connell, will emcee. The conference agenda features:
- Keynote addresses from Ramona Sequeira, President, US Business Unit and Global Portfolio Commercialization, Takeda on driving corporate social justice; and Dr. Chad Womack, Senior Director, STEM Initiatives and the HBCU Innovation, Commercialization, and Entrepreneurship, UNCF on how the life sciences can cultivate, grow, sustain, and support diverse talent
- Martin Rexroad, Chief Culture and Community Officer, PTC; Melissa P. Wu, Ph.D., CEO, Seeding Labs; and Segun Idowu, President, BECMA, who will share their experiences navigating the current sociopolitical environment and provide recommendations for life sciences leaders
- A Possible Talk® from Shannon Resetich, Global Franchise Head, Rare Diseases, Sanofi Genzyme on how companies can create work cultures that champion gender parity, meaningfully support employees in caregiving roles, and foster work-life integration in the “next normal”
- A panel discussion on how employers can reestablish an inclusive company culture as employees return to the office with Emma Lees, Ph.D., SVP, Oncology Discovery Biology, and Head, Mechanisms of Cancer Resistance, Bristol Myers Squibb; Kelley Boucher, Chief Human Resources Officer, Alnylam Pharmaceuticals; Rona Anhalt, Chief People Officer, EQRx; Rose Gailey, Global Lead Organization Acceleration and Senn Delaney Culture Shaping, Heidrick Consulting; and Saraswathy Nochur, Chief DE&I Officer, Alnylam Pharmaceuticals
View the agenda, here.
Interested media can register for free by contacting Caroline Pepek
Sponsors of the event include bluebird bio, Blueprint Medicines, Bristol Myers Squibb, Corealis Pharma, Harvard Pilgrim Health Care, Morgan Stanley, Novo Nordisk, PTC Therapeutics, Sanofi Genzyme, Takeda, Thermo Fisher Scientific, and WR Immigration